These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4549422)

  • 21. [Ambulatory anti-infective therapy. Multicentric studies with cefotaxime treatment of 12,181 patients].
    Pozzi E; Luisetti M; Peona V; Colombo ML
    G Ital Chemioter; 1982; 29(1):21-38. PubMed ID: 6309598
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of different drug forms of novobiocin in dermatological practice].
    Panichkina GS
    Vestn Dermatol Venerol; 1981 Jan; (1):43-7. PubMed ID: 7210869
    [No Abstract]   [Full Text] [Related]  

  • 24. Tigecycline (Tygacil).
    Obstet Gynecol; 2006 Jan; 107(1):178-80. PubMed ID: 16394058
    [No Abstract]   [Full Text] [Related]  

  • 25. Dicloxacillin versus triacetyloleandomycin in upper respiratory infections caused by beta-hemolytic streptococci.
    Mesches DN; Pugliese W; Wiersum J; Taylor RB; Henriquez CL
    N Y State J Med; 1968 Aug; 68(16):2164-7. PubMed ID: 5302159
    [No Abstract]   [Full Text] [Related]  

  • 26. [Piperacillin. A clinical trial in severe infections (author's transl)].
    Ruiz-Palacios GM; Zamora J; Huazano F
    Rev Invest Clin; 1981; 33(3):253-7. PubMed ID: 6460307
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials with cefoperazone in the field of surgery in Japan.
    Shibata K
    Clin Ther; 1980; 3(Spec Issue):173-89. PubMed ID: 6446393
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical experience with clindamycin-2-phosphate in dermatological infections (author's transl)].
    Otaki N; Kagawa
    Jpn J Antibiot; 1977 Feb; 30(2):169-73. PubMed ID: 853575
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
    Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J
    Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of cefuroxime in infective pluriorgan pathology. Observations on 60 cases].
    Failla S; Longo D; Fichera M
    Clin Ter; 1984 Nov; 111(3):227-42. PubMed ID: 6240364
    [No Abstract]   [Full Text] [Related]  

  • 31. [T.A.O. (triacetyloleandomycin) in infectious ENT diseases].
    Dubreuil C; Pignal JL; Muller JP; Costantini JL; Laydevant JP
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Apr; 30(4):265-7. PubMed ID: 6453203
    [No Abstract]   [Full Text] [Related]  

  • 32. Infections in the elderly: current concepts in management.
    Madhavan T
    Compr Ther; 1994; 20(8):465-70. PubMed ID: 7956104
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience with clindamycin-2-phosphate for injection in dermatological field (author's transl)].
    Matsumoto S; Kaneko O; Makino N; Miwa K; Takahashi H
    Jpn J Antibiot; 1977 Jan; 30(1):111-3. PubMed ID: 839634
    [No Abstract]   [Full Text] [Related]  

  • 34. [NBT-test in bacterial and fungal dermatoses (author's transl)].
    Volkmer M; Haustein UF
    Dermatol Monatsschr; 1981 Jan; 167(1):6-11. PubMed ID: 7227596
    [No Abstract]   [Full Text] [Related]  

  • 35. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 37. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with double stranded ribonucleic acid inducing interferon (author's translation)].
    Borecký L; Doskocil J; Lackovic V; Buchvald J; Malý E; Gruntová Z; Obrucník M; Obrucníková E; Havránková M; Vrbovský L; H'radecná Z; Ebringer L; Hlavatý J; Hegyi E
    Cas Lek Cesk; 1977 Jun; 116(22):673-8. PubMed ID: 195731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.